搜索
Celularity Inc
CELU添加自选
0.630USD
+0.032+5.37%
交易中 （美东）报价延迟15分钟
18.17M总市值
亏损市盈率 TTM
关键数据
0.600今开
0.630最高
31.65K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
0.11%换手率
0.598昨收
0.600最低
16.29K成交额
亏损市盈率静
-0.48市净率
0.00%股息率 TTM
-76.43%ROA
4.35052周最高
0.38量比
-57.89M净利润
28.84M总股本
-3.5861每股收益TTM
0.47Beta
-6372.60%ROE
0.71052周最低
5.02%振幅
-88.86%毛利率
18.17M总市值
-7.48回报/风险
5.90%风险率
TradingKey Celularity Inc股票评分
单位: USD 更新时间: 2026-06-30操作建议
Celularity Inc当前公司基本面数据相对稳定，增长潜力较大。当前估值合理，在药品行业排名124/157位。机构持股占比非常高，近一月多位分析师给出公司评级为。最高目标价6.00。中期看，股价处于下降通道。近一个月，市场表现非常差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Celularity Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
Celularity Inc亮点
亮点风险
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
业绩高增长
公司营业收入稳步增长，连续3年增长16.60%
业绩增长期
公司处于发展阶段，最新年度总收入26.55M美元
估值高估
公司最新PE估值-0.17，处于3年历史高位
机构减仓
最新机构持股3.75M股，环比减少6.45%
分析师目标
根据
0
位分析师
--
评级
6.000
目标均价
+889.61%
涨幅空间
Celularity Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Celularity Inc简介
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Biovance 3L, CentaFlex, Interfyl and Rebound products.
公司代码CELU
公司Celularity Inc
CEOHariri (Robert J)
网址https://celularity.com/
相关品种
热门品种
常见问题
Celularity Inc(CELU)的当前股价是多少？
Celularity Inc(CELU)的当前股价是 0.60。
Celularity Inc的股票代码是什么？
Celularity Inc的股票代码是CELU。
Celularity Inc股票的52周最高点是多少？
Celularity Inc股票的52周最高点是4.35。
Celularity Inc股票的52周最低点是多少？
Celularity Inc股票的52周最低点是0.71。
Celularity Inc的市值是多少？
Celularity Inc的市值是17.31M。
Celularity Inc(CELU)股票的每股收益（EPS TTM）是多少
Celularity Inc(CELU)股票的每股收益（EPS TTM）是-3.59。